Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine
Open Access
- 5 February 2014
- journal article
- Published by Springer Nature in Biomarker Research
- Vol. 2 (1) , 3
Abstract
Extensive studies of the genetic aberrations related to human diseases conducted over the last two decades have identified recurrent genomic abnormalities as potential driving factors underlying a variety of cancers. Over the time, a series of cutting-edge high-throughput genetic tests, such as microarrays and next-generation sequencing, have been developed and incorporated into routine clinical practice. Although it is a classical low-throughput cytogenetic test, fluorescence in situ hybridization (FISH) does not show signs of fading; on the contrary, it plays an increasingly important role in detecting specific biomarkers in solid and hematologic neoplasms and has therefore become an indispensable part of the rapidly developing field of personalized medicine. In this article, we have summarized the recent advances in FISH application for both de novo discovery and routine detection of chromosomal rearrangements, amplifications, and deletions that are associated with the pathogenesis of various hematopoietic and non-hematopoietic malignancies. In addition, we have reviewed the recent developments in FISH methodology as well.Keywords
This publication has 99 references indexed in Scilit:
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachJournal of Experimental & Clinical Cancer Research, 2013
- Chronic lymphocytic leukemia: a clinical and molecular heterogenous diseaseCancer Genetics, 2013
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by ProstatectomyCancer Research, 2009
- MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast CancerCancer Cell, 2009
- Molecular profiles of progesterone receptor loss in human breast tumorsBreast Cancer Research and Treatment, 2008
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- Novel patterns of genome rearrangement and their association with survival in breast cancerGenome Research, 2006
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001